Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Simon Flatman
Lancashire, Cumbria, North East Yorkshire & Scotland
Discover the carbon and cost impact of ICS & salbutamol inhaler prescribing in your locality.
Get in touch with your local GSK Account Manager today to access useful tools and resources.
ACT NOW, GO GREEN
It’s time to break the MDI habit and reduce the carbon impact of inhalers
Prescribing Information Links
Flixotide Prescribing Information (PDF)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
GSK may monitor our technology tools and services (including email, phone, and other communications sent to and from GSK) to maintain the security of systems, and to protect our staff, customers and business partners from cyber threats and loss of information. Examples of these monitoring activities include checks for offensive materials, viruses and other malignant code, and unauthorized or unlawful activity.
You can learn about the information that we may process about you, and how we use your information by reading our Privacy policy.
January 2023 PM-GB-CEP-WCNT-220005 (V1.0)
